Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Germ line polymorphism in metastatic progression.

Kent W Hunter1, Nigel P Crawford

  • 1Laboratory of Population Genetics, Center for Cancer Research, National Cancer Institute/NIH, Building 41 Room D702, 41 Library Drive, Bethesda, MD 20892, USA. hunterk@mail.nih.gov

Cancer Research
|February 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NAT10 promotes cancer metastasis by modulating p300/CBP activity through chromatin-associated tRNA.

Molecular cell·2025
Same author

Investigating the genomic landscape of mouse models of breast cancer metastasis.

bioRxiv : the preprint server for biology·2025
Same author

Genetic background and oncogenic driver determines the genomic evolution and transcriptomics of mammary tumor metastasis.

Communications biology·2025
Same author

SMARCD1 is an essential expression-restricted metastasis modifier.

Communications biology·2024
Same author

Resf1 is a compound G4 quadruplex-associated tumor suppressor for triple negative breast cancer.

PLoS genetics·2024
Same author

Loss of NAT10 disrupts enhancer organization via p300 mislocalization and suppresses transcription of genes necessary for metastasis progression.

bioRxiv : the preprint server for biology·2024
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles

Genetic variations, not just tumor mutations, may predispose individuals to cancer metastasis. Identifying these genetic polymorphisms could lead to personalized cancer prevention and treatment strategies for recurrent disease.

Area of Science:

  • Oncology
  • Cancer Genetics
  • Translational Medicine

Background:

  • Somatic genetic analysis reveals genes driving cancer progression.
  • Tumor cell alterations are a known source of cancer variability.
  • Individual differences in metastasis frequency are not fully explained by tumor genetics alone.

Purpose of the Study:

  • To investigate the role of genetic polymorphism in inter-individual variability of cancer metastasis.
  • To explore the potential for genetic predisposition to secondary tumor development.
  • To highlight the implications of identifying cancer-associated polymorphisms for clinical practice.

Main Methods:

  • Analysis of somatic genetic alterations in tumors and metastases.
  • Comparative analysis of genetic polymorphisms across individuals with varying metastasis frequencies.

Related Experiment Videos

  • Characterization of specific polymorphisms linked to metastasis predisposition.

    • Main Results:

    • Somatic alterations in tumor cells are insufficient to explain all variability in metastasis.
    • Genetic polymorphisms represent a significant factor contributing to differences in metastasis frequency.
    • Certain genetic polymorphisms may predispose individuals to developing secondary tumors.

    Conclusions:

    • Genetic polymorphism is a crucial factor in cancer metastasis variability.
    • Identifying these polymorphisms can reveal predispositions to secondary tumor formation.
    • This research opens avenues for tailored cancer prevention and treatment strategies to combat recurrent disease.